• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭注册登记研究:改善心力衰竭患者管理的有效工具。

Heart failure registry: a valuable tool for improving the management of patients with heart failure.

机构信息

Department of Cardiology, Ryhov County Hospital, Jönköping, Sweden.

出版信息

Eur J Heart Fail. 2010 Jan;12(1):25-31. doi: 10.1093/eurjhf/hfp175.

DOI:10.1093/eurjhf/hfp175
PMID:20023041
Abstract

AIMS

Guidelines on how to diagnose and treat patients with heart failure (HF) are published regularly. However, many patients do not fulfil the diagnostic criteria and are not treated with recommended drugs. The Swedish Heart Failure Registry (S-HFR) is an instrument which may help to optimize the handling of HF patients.

METHODS AND RESULTS

The S-HFR is an Internet-based registry in which participating centres (units) can record details of their HF patients directly online and transfer data from standardized forms or from computerized patient documentation. Up to December 2007, 16,117 patients from 78 units had been included in the S-HFR. Of these, 10,229 patients had been followed for at least 1 year, and 2133 deaths were recorded. Online reports from the registry showed that electrocardiograms were available for 97% of the patients. Sinus rhythm was found in 51% of patients and atrial fibrillation in 38%. Echocardiography was performed in 83% of the patients. Overall, 77% of patients were treated with angiotensin converting enzyme inhibitors or angiotensin II receptor blockers, 80% were on beta-blockers, 34% on aldosterone antagonists, and 83% on diuretics.

CONCLUSION

The S-HFR is a valuable tool for improving the management of patients with HF, since it enables participating centres to focus on their own potential for improving diagnoses and medical treatment, through the online reports provided.

摘要

目的

有关心力衰竭(HF)患者诊断和治疗的指南定期发布。然而,许多患者并未满足诊断标准,也未接受推荐的药物治疗。瑞典心力衰竭注册(S-HFR)是一种可能有助于优化 HF 患者处理方式的工具。

方法和结果

S-HFR 是一个基于互联网的注册系统,参与中心(单位)可以直接在线记录其 HF 患者的详细信息,并从标准化表格或计算机化患者文档中传输数据。截至 2007 年 12 月,已有 78 个单位的 16117 名患者纳入 S-HFR。其中,10229 名患者至少随访 1 年,记录了 2133 例死亡。来自该注册系统的在线报告显示,97%的患者可提供心电图。51%的患者为窦性心律,38%为心房颤动。83%的患者接受了超声心动图检查。总体而言,77%的患者接受了血管紧张素转换酶抑制剂或血管紧张素 II 受体阻滞剂治疗,80%接受了β受体阻滞剂治疗,34%接受了醛固酮拮抗剂治疗,83%接受了利尿剂治疗。

结论

S-HFR 是改善 HF 患者管理的有价值工具,因为它使参与中心能够通过提供的在线报告,关注自身改善诊断和医疗的潜力。

相似文献

1
Heart failure registry: a valuable tool for improving the management of patients with heart failure.心力衰竭注册登记研究:改善心力衰竭患者管理的有效工具。
Eur J Heart Fail. 2010 Jan;12(1):25-31. doi: 10.1093/eurjhf/hfp175.
2
Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.根据左心室射血分数优化心力衰竭出院后的医疗治疗:FUTURE 调查。
Arch Cardiovasc Dis. 2012 Jun-Jul;105(6-7):355-65. doi: 10.1016/j.acvd.2012.04.003. Epub 2012 Jun 28.
3
Clinical presentation, management, in-hospital and 90-day outcomes of heart failure patients in Trivandrum, Kerala, India: the Trivandrum Heart Failure Registry.印度喀拉拉邦特里凡得琅心力衰竭患者的临床表现、治疗、住院期间和 90 天结局:特里凡得琅心力衰竭注册研究。
Eur J Heart Fail. 2015 Aug;17(8):794-800. doi: 10.1002/ejhf.283. Epub 2015 May 23.
4
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.心力衰竭的住院或门诊患者是否按照欧洲心脏病学会指南进行治疗?来自 ESC 心力衰竭长期注册研究的 12440 例患者的证据。
Eur J Heart Fail. 2013 Oct;15(10):1173-84. doi: 10.1093/eurjhf/hft134. Epub 2013 Aug 26.
5
Increased comorbidities in heart failure patients ≥ 85 years but declined from >90 years: data from the Swedish Heart Failure Registry.心力衰竭患者≥85 岁的合并症增加,但>90 岁的合并症减少:来自瑞典心力衰竭登记处的数据。
Int J Cardiol. 2013 Sep 10;167(6):2747-52. doi: 10.1016/j.ijcard.2012.06.095. Epub 2012 Jul 16.
6
Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.门诊心脏病学实践中患者年龄和性别对指南推荐的心力衰竭护理实施的影响:IMPROVE HF研究结果
Am Heart J. 2009 Apr;157(4):754-62.e2. doi: 10.1016/j.ahj.2008.12.016.
7
[Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].[1995年至2005年IN-CHF注册研究中药理学治疗的时间趋势]
G Ital Cardiol (Rome). 2007 Feb;8(2):102-6.
8
B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF.门诊心力衰竭患者 B 型利钠肽评估:来自 IMPROVE HF 的见解。
J Cardiovasc Med (Hagerstown). 2012 Jun;13(6):360-7. doi: 10.2459/JCM.0b013e328353128c.
9
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.收缩功能保留的心力衰竭住院患者的特征、治疗及结局:OPTIMIZE-HF注册研究报告
J Am Coll Cardiol. 2007 Aug 21;50(8):768-77. doi: 10.1016/j.jacc.2007.04.064. Epub 2007 Aug 6.
10
Influence of drug adherence and medical care on heart failure outcome in the primary care setting in Austria.药物依从性和医疗护理对奥地利初级医疗环境中心力衰竭结局的影响。
Pharmacoepidemiol Drug Saf. 2015 Jul;24(7):722-30. doi: 10.1002/pds.3790. Epub 2015 May 18.

引用本文的文献

1
Supranormal Ejection Fraction in Heart Failure: Exploring the Heterogeneity of a Distinct Clinical Phenotype.心力衰竭中超正常射血分数:探索一种独特临床表型的异质性
J Am Heart Assoc. 2025 Mar 18;14(6):e040833. doi: 10.1161/JAHA.125.040833. Epub 2025 Mar 13.
2
The Icelandic Heart Failure Registry-A nationwide assessment tool for HF care and intervention in HF treatment.冰岛心力衰竭登记处——一种用于心力衰竭护理及治疗干预的全国性评估工具。
ESC Heart Fail. 2024 Dec;11(6):4081-4091. doi: 10.1002/ehf2.15012. Epub 2024 Aug 6.
3
Heart failure patients without echocardiography are more commonly diagnosed in hospital care and are associated with higher mortality compared to primary care.
心力衰竭患者在医院护理中更常被诊断出来,而不是在初级保健中,且与更高的死亡率相关,而这些患者没有进行超声心动图检查。
Scand J Prim Health Care. 2024 Mar;42(1):29-37. doi: 10.1080/02813432.2023.2283186. Epub 2024 Feb 7.
4
Interamerican Society of Cardiology (CIFACAH - ELECTROSIAC)/Latin American Heart Rhythm Society (LAHRS): multidisciplinary review on the appropriate use of cardiac resynchronization therapy in heart failure.美洲心脏病学会(CIFACAH-ELECTROSIAC)/拉丁美洲心脏节律学会(LAHRS):心力衰竭中心脏再同步治疗的适当使用多学科综述。
Arch Cardiol Mex. 2023;93(Supl):39-53. doi: 10.24875/ACM.23000061.
5
Impact of adherence to guideline-directed therapy on risk of death in HF patients across an ejection fraction spectrum.依指南指导的治疗依从性对射血分数谱心衰患者死亡风险的影响。
ESC Heart Fail. 2023 Dec;10(6):3656-3666. doi: 10.1002/ehf2.14358. Epub 2023 Oct 6.
6
Changing health related quality of life and outcomes in heart failure by age, sex and subtype.心力衰竭患者健康相关生活质量及预后随年龄、性别和亚型的变化情况
EClinicalMedicine. 2023 Sep 14;64:102217. doi: 10.1016/j.eclinm.2023.102217. eCollection 2023 Oct.
7
Global Variations in Heart Failure Etiology, Management, and Outcomes.全球心力衰竭病因、治疗和结局的差异。
JAMA. 2023 May 16;329(19):1650-1661. doi: 10.1001/jama.2023.5942.
8
What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey II.是什么决定了欧洲的哪些患者可以接受心脏再同步治疗?ESC-HF-LT 注册研究、SwedeHF 注册研究和 ESC-CRT 调查 II 的比较。
Eur Heart J Qual Care Clin Outcomes. 2023 Dec 22;9(8):741-748. doi: 10.1093/ehjqcco/qcad024.
9
Association of digoxin with mortality and rehospitalization in heart failure patients treated with beta-blockers: Results from the Persian Heart Failure Patient Registry.在接受β受体阻滞剂治疗的心力衰竭患者中地高辛与死亡率和再住院率的关联:来自波斯心力衰竭患者登记处的结果
ARYA Atheroscler. 2022 May;18(3):1-10. doi: 10.48305/arya.v18i0.2329.
10
The Danish Heart Failure Registry: A Validation Study of Content.丹麦心力衰竭登记处:内容的验证研究
Clin Epidemiol. 2022 Dec 28;14:1585-1594. doi: 10.2147/CLEP.S390898. eCollection 2022.